White House announces new round of drug-price deals
President Trump said the administration has reached agreements with nine more drugmakers to bring their U.S. drug prices more in line with what other wealthy countries pay.
Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals. The companies that took part in Friday’s announcement were: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi.
They agreed to charge the U.S. government no more for new drugs than the prices paid by other well-off countries. The agreements will allow state Medicaid programs to access lower prices from the nine companies. In a statement, the White House said the change will result “in billions of dollars in savings.”
The drugmakers also agreed to invest at least $150 billion in manufacturing operations in the U.S. The president is seeking to increase domestic production of pharmaceuticals.
In addition, the companies agreed to make some of their most popular drugs available at lower prices to consumers who pay out of pocket through a government website called TrumpRx.com. The TrumpRx website is expected to launch in early 2026, and would take consumers to pharmaceutical companies’ direct-to-consumer websites to fulfill orders.
For example, Merck will reduce the price of Januvia, a medication for Type 2 diabetes, from $330 to $100 for patients purchasing directly through TrumpRx, the White House said. Amgen will reduce the price of Repatha, a cholesterol-lowering drug, from $573 to $239 when purchased through TrumpRx.
In exchange for these concessions, the companies will be exempt from possible administration tariffs for three years.
The extent of savings for consumers under the agreements is unclear. Medicaid and its beneficiaries already pay some of the lowest prices for drugs. And people with health insurance could spend less on copays for their medicines than paying cash for them through the drugmakers.
Separately, Trump said during the press event that he would like to get health insurers to lower their prices, too.
“I’m going to call a meeting of the insurance companies,” he said. “I’m going to see if they [will] get their price down, to put it very bluntly.”
Special elections ordered for Mississippi Supreme Court after voting rights violation
A federal judge ordered special elections after earlier ordering the state to redraw the electoral map used to select justices, concluding the current configuration dilutes the power of Black voters.
Opinion: Remembering the lives lost to a senseless act of terror
The attack at Australia's Bondi Beach earlier this week on people who were celebrating the first night of Hanukkah was horrific. Stories have emerged about those who died trying to stop the gunmen.
Trump’s push to end transgender care for young people opposed by pediatricians
Doctors and children's hospitals say nothing in the evidence has changed to justify the Trump administration's efforts to ban gender-affirming care for teens and tweens.
It was called the Kennedy Center, but 3 different presidents shaped it
Washington, D.C.'s performing arts center was named for President Kennedy after his assassination. But his vision for the arts as a cornerstone of democracy was shared by Eisenhower and Johnson.
Justice Department begins the release of the Epstein files
The Justice Department has begun publishing the Epstein files, releasing documents related to convicted sex offender Jeffrey Epstein's criminal charges and his death by suicide in federal custody.
Judge blocks HUD homelessness overhaul, rebukes agency for causing ‘chaos’
A federal judge said HUD cannot dramatically change its funding policies on homelessness for now. States, cities and nonprofits say the proposed overhaul would push thousands back onto the streets.
